PTC THERAPEUTICS, INC. (PTCT)
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications. Among its commercialized products, PTC Therapeutics provides Translarna and Emflaza, offering therapeutic options for Duchenne muscular dystrophy patients in the European Economic Area and the United States. Translarna also addresses nonsense mutation Duchenne muscular dystrophy in Brazil and Russia. The company additionally commercializes Tegsedi and Waylivra for various rare conditions throughout Latin America and the Caribbean. Furthermore, in Brazil, PTC Therapeutics distributes Evrysdi as a treatment for spinal muscular atrophy (SMA) in patients aged two months and older. Leveraging its proprietary splicing platform, the company is also actively developing PTC518, a promising therapeutic candidate aimed at treating Huntington's disease. To bolster its research and development capabilities, PTC Therapeutics has established strategic collaborations, including partnerships with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation, focusing on advancing drug discovery and development research, particularly in regenerative medicine. Additionally, it collaborates with Akcea Therapeutics, Inc. for the commercialization of Tegsedi and Waylivra in the Latin America and Caribbean region. Established in 1998, PTC Therapeutics, Inc. maintains its corporate headquarters in South Plainfield, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
PTC Therapeutics, Inc.
NASDAQ:PTCTHealthcare · Biotechnology
-6.97%$59.97
AH$61.55+2.63%vs close
Mkt Cap$5.01B
Float79.27M
O/S83.54M
Vol
$ Vol
RVOL
Inst Own-
SI10.5%
Earnings
Dilution
Financials Summary
Revenue$1.73B
Net Income$682.64M
Total Assets$2.9B
Free Cash Flow$411.18M
Debt & Equity
Debt 108%
Total Debt$2.71B
Total Equity-$205.31M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in PTCT's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$2.9B
Liabilities$3.1B
Accounts Receivable$181.62M
Accounts Payable$45.49M
Inventory$79.65M
PP&E (Net)$135.42M
Goodwill$82.34M
Intangible Assets$388.75M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $1.73B | $806.78M | $937.82M | $698.8M | $538.59M | $380.77M | $306.98M | $264.73M | $194.39M | $82.7M | $36.77M | $22.96M | $31.33M | $28.78M | $98.96M |
| YoY Growth | 114.5% | -14.0% | 34.2% | 29.7% | 41.4% | 24.0% | 16.0% | 36.2% | 135.0% | 124.9% | 60.1% | -26.7% | 8.9% | -70.9% | - |
| Cost of Revenue | $71.75M | $57.4M | $65.49M | $44.68M | $32.33M | $18.94M | $12.13M | $12.67M | $4.58M | $117.63M | $121.82M | $79.84M | $54.88M | -$5.17M | $0 |
| Gross Profit | $1.66B | $749.38M | $872.34M | $654.12M | $506.26M | $361.82M | $294.85M | $252.06M | $189.81M | -$34.93M | -$85.05M | -$56.88M | -$23.55M | $33.95M | $98.96M |
| Gross Margin | 95.9% | 92.9% | 93.0% | 93.6% | 94.0% | 95.0% | 96.0% | 95.2% | 97.6% | -42.2% | -231.3% | -247.7% | -75.2% | 118.0% | 100.0% |
| Research and Development | $455.25M | $534.48M | $666.56M | $651.5M | $540.68M | $477.64M | $257.45M | $171.98M | $117.46M | $117.63M | $121.82M | $79.84M | $54.88M | $46.14M | $58.68M |
| Selling, General, and Administrative | $347.14M | $300.91M | $332.54M | $326M | $285.77M | $245.16M | $202.54M | $153.55M | $121.27M | $97.13M | $82.08M | $44.82M | $25.22M | $14.62M | $16.15M |
| Other | $0 | $216.56M | $312.74M | $124.04M | $54.25M | $70.78M | $76.01M | $129K | -$1.28M | -$1.21M | -$465K | -$213K | $38K | $1.78M | $461K |
| Total Operating Expenses | $802.39M | $1.05B | $1.31B | $1.1B | $880.71M | $793.59M | $536M | $348.41M | $254.11M | $214.76M | $203.9M | $122.38M | $76.72M | $55.59M | $68.38M |
| Operating Income (EBIT) | $856.51M | -$302.57M | -$439.5M | -$447.41M | -$374.44M | -$431.77M | -$241.16M | -$115.69M | -$64.29M | -$132.06M | -$167.13M | -$99.41M | -$45.4M | -$26.81M | $30.58M |
| Operating Margin | 49.5% | -37.5% | -46.9% | -64.0% | -69.5% | -113.4% | -78.6% | -43.7% | -33.1% | -159.7% | -454.6% | -432.9% | -144.9% | -93.2% | 30.9% |
| Interest Expense | $152.23M | $166.99M | $129.18M | $90.87M | $86.02M | $56.35M | $12.49M | $12.55M | $12.09M | $8.28M | $2.37M | $1.18M | $6.08M | $1.21M | $2.44M |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$159.89M | -$60.55M | -$256.61M | -$140.08M | -$143.9M | $28.84M | $1.23M | -$12.43M | -$13.37M | -$9.48M | -$2.83M | $967K | -$6.18M | $573K | -$1.98M |
| Income Before Tax (EBT) | $696.62M | -$363.12M | -$696.11M | -$587.49M | -$518.34M | -$402.93M | -$239.93M | -$128.11M | -$77.67M | -$141.54M | -$169.96M | -$98.45M | -$51.57M | -$26.24M | $28.6M |
| Income Tax Expense | $13.97M | $176K | -$69.51M | -$28.47M | $5.56M | $35.23M | $11.65M | -$29K | $1.33M | $569K | $485K | -$4.69M | $6.21M | $1.21M | -$2.31M |
| Net Income | $682.64M | -$363.3M | -$626.6M | -$559.02M | -$523.9M | -$438.16M | -$251.58M | -$128.08M | -$79M | -$142.11M | -$170.45M | -$93.75M | -$51.57M | -$26.24M | $30.9M |
| Net Income Margin | 39.4% | -45.0% | -66.8% | -80.0% | -97.3% | -115.1% | -82.0% | -48.4% | -40.6% | -171.8% | -463.6% | -408.3% | -164.6% | -91.2% | 31.2% |
| Supplementary Data | |||||||||||||||
| EPS | 8.58 | -4.73 | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 | -5.07 | -2.97 | -4.02 | -1.85 | 0.00 |
| Diluted EPS | 7.78 | -4.73 | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 | -5.07 | -2.97 | -4.02 | -1.11 | 0.00 |
| Weighted Average OS | 79.53M | 76.85M | 74.84M | 71.73M | 70.47M | 66.03M | 58.86M | 46.58M | 39.11M | 34.04M | 33.62M | 31.57M | 12.82M | 14.19M | 14.19M |
| EBITDA | $887.66M | -$120.46M | -$330.34M | -$367.78M | -$368.18M | -$303.09M | -$195.25M | -$89.47M | -$46.61M | -$128.77M | -$164.25M | -$97.18M | -$43M | -$24.1M | $33.45M |
| EBITDA Margin | 51.3% | -14.9% | -35.2% | -52.6% | -68.4% | -79.6% | -63.6% | -33.8% | -24.0% | -155.7% | -446.8% | -423.2% | -137.3% | -83.8% | 33.8% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $984.65M | $779.71M | $594M | $279.83M | $189.72M | $208.81M | $288.03M | $227.59M | $191.25M | $231.67M | $338.93M | $315.24M | $15.41M | $2.73M | $28.43M |
| Short-Term Investments | $960.72M | $359.99M | $282.74M | $130.87M | $583.66M | $894.84M | $398.54M | $0 | $0 | $0 | $0 | $0 | $127.05M | $0 | $0 |
| Cash and Short-Term Investments | $1.95B | $1.14B | $876.74M | $410.7M | $773.38M | $1.1B | $686.56M | $227.59M | $191.25M | $231.67M | $338.93M | $315.24M | $142.47M | $2.73M | $28.43M |
| Accounts Receivable | $181.62M | $158.55M | $160.82M | $155.61M | $110.45M | $69.93M | $55.54M | $67.91M | $40.39M | $24.93M | $11.09M | $4.45M | $958K | $1.01M | $1.24M |
| Inventory | $79.65M | $23.19M | $30.58M | $21.81M | $15.86M | $18.7M | $19.29M | $16.12M | $10.75M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $67.31M | $44.09M | $150.49M | $105.66M | $0 | $0 | $0 | $9.25M | $6.67M | $4.69M | $5.93M | $3.88M | $0 | $0 | $0 |
| Total Current Assets | $2.27B | $1.37B | $1.22B | $693.78M | $954.37M | $1.23B | $779.28M | $320.86M | $249.06M | $261.29M | $355.95M | $323.57M | $145.02M | $4.6M | $33.05M |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $135.42M | $117.66M | $178.99M | $175.02M | $130.01M | $118.24M | $35.24M | $12.69M | $8.38M | $7.43M | $8.97M | $9.16M | $6.73M | $8.28M | $10.8M |
| Goodwill | $82.34M | $82.34M | $82.34M | $82.34M | $82.34M | $82.34M | $82.34M | $82.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $388.75M | $118.79M | $379.5M | $705.89M | $724.84M | $715.33M | $710.5M | $701.03M | $132.99M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $18.3M | $20.7M | $36.25M | $48.58M | $46.5M | $60.62M | $16.41M | $2.3M | $1.22M | $630K | $3.12M | $489K | $149K | $197K | $298K |
| Total Long-Term Assets | $624.82M | $339.49M | $677.07M | $1.01B | $983.69M | $976.53M | $844.5M | $798.37M | $142.59M | $8.06M | $12.09M | $9.65M | $6.88M | $8.48M | $11.09M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.9B | $1.71B | $1.9B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $391.65M | $269.35M | $368.04M | $333.22M | $151.9M | $13.07M | $44.15M |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $45.49M | $17.27M | $6.04M | $27.27M | $23.03M | $18.66M | $10.32M | $6M | $15.28M | $6.3M | $5.78M | $4.13M | $1.12M | $622K | $1.88M |
| Short-Term Debt | $569.63M | $257.82M | $194.31M | $72.15M | $208.83M | $0 | $20M | $11.67M | $0 | $0 | $0 | $0 | $49K | $4.44M | $7.14M |
| Current Income Tax Payable | $0 | $4.7M | $0 | $4.71M | $1.29M | $4.32M | $499K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $2.04M | $5.5M | $801K | $1.35M | $0 | $4.15M | $8.24M | $3.72M | $3.94M | $1.59M | $139K | $3.35M | $877K | $16.69M | $22.96M |
| Other Current Liabilities | $202.93M | $120.22M | $139.82M | $126.46M | $118.86M | $129.89M | $120.16M | $117.78M | $45.12M | $29.68M | $26.84M | $15.68M | $5.98M | $3.1M | $3.49M |
| Total Current Liabilities | $968.43M | $580.98M | $603.1M | $406.24M | $509.35M | $277.33M | $235.86M | $166.8M | $82.05M | $49.62M | $45.39M | $32.48M | $13.13M | $28.16M | $43.15M |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $2.03B | $2.11B | $1.9B | $1.26B | $956.59M | $309.14M | $293.86M | $141.35M | $144.97M | $98.22M | $91.85M | $0 | $0 | $439K | $4.55M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $3.42M | $13.44M | $11.89M | $1.59M | $139K | $3.35M | $0 | $742K | $16.45M |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $55.91M | $102.83M | $137.11M | $136.74M | $130.86M | $122.03M | -$3.94M | $0 | -$139K | $0 | $0 | $378K | $214.38M |
| Other Long-Term Liabilities | $13.7M | $22.23M | $36.44M | $166.64M | $239.9M | $900.53M | $356.44M | $328.6M | $243K | $335K | $2.05M | $2.28M | $2.23M | $2.55M | $4.23M |
| Total Long-Term Liabilities | $2.14B | $2.22B | $2.11B | $1.65B | $1.43B | $1.45B | $793.6M | $601.7M | $153.17M | $100.14M | $96.65M | $2.28M | $2.23M | $4.11M | $239.61M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$72.47M | $0 | $0 | $0 | $0 |
| Total Liabilities | $3.1B | $2.8B | $2.71B | $2.05B | $1.94B | $1.73B | $1.03B | $768.5M | $235.22M | $149.76M | $69.57M | $34.75M | $15.36M | $32.27M | $282.75M |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $31K | $485K | $72.67M | $0 | $151.9B | $80.45M | $0 |
| Common Stock | $80K | $77K | $75K | $72K | $71K | $70K | $62K | $51K | $42K | $34K | $34K | $33K | $24K | $545 | $133 |
| Retained Earnings | -$2.96B | -$3.65B | -$3.28B | -$2.66B | -$2.1B | -$1.63B | -$1.19B | -$938.92M | -$814.11M | -$735.11M | -$593M | -$422.55M | -$328.8M | -$277.22M | -$250.61M |
| Comprehensive Income & Other | $10.5M | -$25.89M | -$1.28M | $4.8M | -$24.28M | -$60.96M | -$10.58M | $1.46M | $3.97M | -$1.49M | -$1.2M | -$737K | $70K | -$20.29M | -$17.58M |
| Other Stockholders' Equity | $2.76B | $2.55B | $2.46B | $2.31B | $2.1B | $2.11B | $1.78B | $1.29B | $970.5M | $854.66M | $891.43M | $720.99M | $465.32M | $258.03M | $12.01M |
| Total Equity | -$205.31M | -$1.1B | -$818.55M | -$347.09M | $1.44M | $481.98M | $594.33M | $350.73M | $156.44M | $119.58M | $298.47M | $298.47M | $136.54M | -$19.19M | -$238.6M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.9B | $1.71B | $1.9B | $1.71B | $1.94B | $2.21B | $1.62B | $1.12B | $391.65M | $269.35M | $368.04M | $333.22M | $151.9M | $13.07M | $44.15M |
| Supplementary Data | |||||||||||||||
| Total Debt | $2.71B | $2.47B | $2.23B | $1.46B | $1.27B | $420.44M | $328.03M | $153.01M | $144.97M | $98.22M | $94.61M | $0 | $49K | $4.88M | $11.69M |
| Net Debt | $1.72B | $1.69B | $1.64B | $1.18B | $1.08B | $211.63M | $40M | -$74.57M | -$46.27M | -$133.45M | -$244.32M | -$315.24M | -$15.37M | $2.16M | -$16.74M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | $682.64M | -$363.3M | -$626.6M | -$559.02M | -$523.9M | -$438.16M | -$251.58M | -$128.08M | -$79M | -$142.11M | -$170.45M | -$93.75M | -$51.57M | -$26.24M | $30.9M |
| Depreciation & Amortization | $38.81M | $75.66M | $236.59M | $128.84M | $64.13M | $43.49M | $32.18M | $26.09M | $17.68M | $3.29M | $2.88M | $2.23M | $2.4M | $2.7M | $2.87M |
| Deferred Income Tax | -$3K | -$55.91M | -$46.93M | -$34.28M | $377K | $5.87M | $8.83M | -$490K | $199K | -$199K | $2.3M | -$19.31M | $92K | -$1.78M | -$462K |
| Stock-Based Compensation | $74.55M | $74.61M | $131.21M | $110.33M | $103.51M | $70.33M | $42.13M | $33.25M | $30.56M | $35.01M | $33.98M | $19.31M | $8.43M | $2.29M | $2.82M |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | -$10.15M | $1.73M | -$1.54M | -$48.47M | -$44.99M | -$10.48M | $11.53M | -$29.59M | -$12.2M | -$14.84M | -$6.91M | -$3.49M | $56K | $230K | $0 |
| Inventory | -$53.9M | $6.16M | -$8.18M | -$6.67M | $1.8M | $1.84M | -$3.46M | -$5.82M | -$6.45M | $893K | -$1.98M | -$2.63M | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $27.54M | $23.41M | $53.59M | $13.75M | $43.11M | $24.01M | $4.26M | $16.98M | $16.91M | $5.18B | $0 | $0 |
| Other Working Capital | $16.17M | $94.65M | $5.72M | -$57.74M | -$4.01M | -$8.03M | -$1.39M | $6.51M | $7.87M | $727K | -$3.4M | $2.4M | -$5.2B | -$25.13M | -$57.31M |
| Total Working Capital Change | -$47.88M | $102.54M | -$4M | -$85.33M | -$23.79M | $36.91M | $20.43M | $14.21M | $13.23M | -$8.96M | $4.7M | $13.2M | -$12.31M | -$25.13M | -$57.31M |
| Other Non-Cash Items | -$36.93M | $58.7M | $151.32M | $82.81M | $128.33M | $87.49M | $49.37M | $27.38M | $7.27M | $9.41M | $2.25M | $21.05M | $6.05M | $226K | $417K |
| Net Cash from Operating | $711.2M | -$107.69M | -$158.42M | -$356.65M | -$251.33M | -$194.07M | -$98.64M | -$27.64M | -$10.06M | -$103.57M | -$124.34M | -$57.27M | -$46.92M | -$47.93M | -$20.77M |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$8.86M | -$6.5M | -$28.44M | -$152.46M | -$85.33M | -$55.98M | -$45.44M | -$15.53M | -$3.1M | -$1.78M | -$2.72M | -$4.66M | -$846K | -$189K | -$165K |
| Acquisitions | $0 | $0 | $0 | $128.44M | $57.12M | $38.13M | -$4M | -$48.89M | -$77.16M | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$1.42B | -$667.36M | -$212.48M | -$75.55M | -$543.27M | -$1.45B | -$494.07M | -$68.61M | -$81.37M | -$85.38M | -$223.76M | -$247.8M | -$156.04M | $0 | -$2.02M |
| Sales of Investments | $855.12M | $607.74M | $156.37M | $518.19M | $847.78M | $944.09M | $156.27M | $90.42M | $174.75M | $191.63M | $205.67M | $107.3M | $29.06M | $0 | $29.89M |
| Other Investing Activities | -$291.08M | $110.31M | -$92.18M | -$128.44M | -$57.12M | -$38.13M | $0 | $13.38M | $16.22M | $106.26M | -$18.09M | -$140.5M | -$126.98M | $0 | $0 |
| Net Cash from Investing | -$861.98M | $44.18M | -$176.74M | $290.18M | $219.18M | -$561.55M | -$387.24M | -$42.61M | $13.12M | $104.48M | -$20.81M | -$145.17M | -$127.83M | -$189K | $27.7M |
| Financing Activities | |||||||||||||||
| Debt Repaid | $1.61M | $1.49M | $301.38M | -$148.72M | $2.22M | $46.16M | -$267.6M | - | -$40M | - | -$150M | $49K | $5M | $6.94M | $7.19M |
| Common Stock Issuance | $99.05M | $0 | $0 | $50M | $23.1M | $28.09M | $323.76M | $117.92M | $2.47M | $968K | $8.71M | $235.98M | $131.65M | $0 | $6K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $233.66M | $257.36M | $947.78M | -$30.77M | $0 | $686.78M | $21.85M | $13.65M | $4.22M | $968K | $4.06M | $1.2M | $51 | $0 | $0 |
| Net Cash from Financing | $331.09M | $255.87M | $646.4M | $167.95M | $20.88M | $668.72M | $613.21M | $131.57M | $44.22M | $968K | $154.06M | $237.13M | $187.44M | $22.41M | -$7.18M |
| Forex Effect | $22.71M | -$7.33M | $3.11M | -$2.77M | -$7.82M | $7.69M | -$1.3M | -$3.61M | $6.2M | -$1.58M | -$639K | -$350K | $0 | $0 | $0 |
| Net Change in Cash | $203.02M | $185.03M | $314.36M | $98.71M | -$19.09M | -$79.22M | $126.03M | $57.71M | $53.47M | $299K | $8.27M | $34.33M | $12.69M | -$25.71M | -$243K |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | $711.2M | -$107.69M | -$158.42M | -$356.65M | -$251.33M | -$194.07M | -$98.64M | -$27.64M | -$10.06M | -$103.57M | -$124.34M | -$57.27M | -$46.92M | -$47.93M | -$20.77M |
| Capital Expenditure | -$300.01M | -$74.25M | -$120.62M | -$152.46M | -$85.33M | -$55.98M | -$45.44M | -$15.53M | -$3.1M | -$1.78M | -$2.72M | -$4.66M | -$846K | -$189K | -$165K |
| Free Cash Flow | $411.18M | -$181.94M | -$279.04M | -$509.11M | -$336.66M | -$250.05M | -$144.08M | -$43.17M | -$13.16M | -$105.34M | -$127.06M | -$61.94M | -$47.77M | -$48.12M | -$20.93M |
| Cash at Beginning | $795.32M | $610.28M | $295.93M | $197.22M | $216.31M | $295.53M | $169.5M | $111.79M | $58.32M | $58.02M | $49.75M | $15.41M | $2.73M | $28.43M | $28.67M |
| Cash at End | $998.33M | $795.32M | $610.28M | $295.93M | $197.22M | $216.31M | $295.53M | $169.5M | $111.79M | $58.32M | $58.02M | $49.75M | $15.41M | $2.73M | $28.43M |